risedronic acid has been researched along with Medial Calcific Sclerosis in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saitoh, E | 1 |
| Nagae, Y | 1 |
| Wachi, H | 1 |
| Seyama, Y | 1 |
1 review available for risedronic acid and Medial Calcific Sclerosis
| Article | Year |
|---|---|
[Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis].
Topics: Animals; Bone Density Conservation Agents; Cattle; Etidronic Acid; Extracellular Matrix; Female; Hum | 2008 |